These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2836520)

  • 1. Use of interleukin-2 and macrophages to treat herpes simplex virus infection in neonatal mice.
    Kohl S; Loo LS
    J Infect Dis; 1988 Jun; 157(6):1187-92. PubMed ID: 2836520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective production of anti-herpes simplex virus antibody by neonatal mice. Reconstitution with Ia+ macrophages and T helper lymphocytes from nonimmune adult syngeneic mice.
    Kohl S; Thomas JW; Loo LS
    J Immunol; 1986 Apr; 136(8):3038-44. PubMed ID: 3007609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective production of antibody to herpes simplex virus in neonates: defective production of T helper lymphokine and induction of suppression.
    Kohl S; Cox PA; Loo LS
    J Infect Dis; 1987 Jun; 155(6):1179-87. PubMed ID: 3033093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-2 protects neonatal mice from lethal herpes simplex virus infection: a macrophage-mediated, gamma interferon-induced mechanism.
    Kohl S; Loo LS; Drath DB; Cox P
    J Infect Dis; 1989 Feb; 159(2):239-47. PubMed ID: 2492588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
    Kohl S; Loo LS
    J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of immunostimulants on resistance of newborn mice to herpes simplex type 2 infection.
    Starr SE; Visintine AM; Tomeh MO; Nahmias AJ
    Proc Soc Exp Biol Med; 1976 May; 152(1):57-60. PubMed ID: 177992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of newborn mice from a lethal herpes simplex virus infection by human interferon, antibody, and leukocytes.
    Kohl S; Loo LS; Greenberg SB
    J Immunol; 1982 Mar; 128(3):1107-11. PubMed ID: 6173420
    [No Abstract]   [Full Text] [Related]  

  • 8. Murine cellular cytotoxicity to syngeneic and xenogeneic herpes simplex virus-infected cells.
    Kohl S; Drath DB; Loo LS
    Infect Immun; 1982 Dec; 38(3):1231-41. PubMed ID: 6295943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of antibody-dependent cellular cytotoxicity in neonatal infection with herpes simplex virus.
    Kohl S
    Rev Infect Dis; 1991; 13 Suppl 11():S950-2. PubMed ID: 1664132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against murine neonatal herpes simplex virus infection by lymphokine-treated human leukocytes.
    Kohl S
    J Immunol; 1990 Jan; 144(1):307-12. PubMed ID: 2153165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant interleukin-1 alpha, interleukin-2 and M-CSF-1 enhance the survival of newborn C57BL/6 mice inoculated intraperitoneally with a lethal dose of herpes simplex virus-1.
    Berkowitz C; Becker Y
    Arch Virol; 1992; 124(1-2):83-93. PubMed ID: 1571022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cytotoxicity and antibody-dependent cell cytotoxicity to herpes simplex virus-infected target cells in murine pregnancy.
    Loftin KC; Gonik B; Kumaran P
    Am J Reprod Immunol Microbiol; 1988 Jun; 17(2):53-6. PubMed ID: 2847568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-linkage of the early in vitro alpha/beta interferon response of mouse peritoneal macrophages to herpes simplex virus type 2.
    Ellermann-Eriksen S; Liberto MC; Iannello D; Mogensen SC
    J Gen Virol; 1986 Jun; 67 ( Pt 6)():1025-33. PubMed ID: 3011968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody to cloned HSV glycoproteins B and D plus adult human leukocytes protect neonatal mice from lethal HSV infection.
    Bernstein DI; Loo LS; Kohl S
    Antiviral Res; 1988 Dec; 10(6):279-87. PubMed ID: 2854958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postexposure serum prophylaxis of neonatal herpes simplex virus infection of mice.
    Baron S; Worthington MG; Williams J; Gaines JW
    Nature; 1976 Jun; 261(5560):505-6. PubMed ID: 180414
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunotherapy and drugs in neonatal disseminated herpes simplex virus type 2 infections: a mouse model.
    Strulovitch C; Marks MI; Soneji A; Goldberg S
    J Antimicrob Chemother; 1979 Jul; 5(4):437-46. PubMed ID: 226512
    [No Abstract]   [Full Text] [Related]  

  • 18. Ontogeny of murine cellular cytotoxicity to herpes simplex virus-infected cells.
    Kohl S; Loo LS
    Infect Immun; 1980 Dec; 30(3):847-50. PubMed ID: 6262242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive immunotherapy for encephalitis caused by herpes simplex virus.
    Erlich KS; Mills J
    Rev Infect Dis; 1986; 8 Suppl 4():S439-45. PubMed ID: 3018895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
    Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT
    J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.